Back to Search
Start Over
Prescription Medication Use in Pregnancy in People with Disabilities: A Population-Based Cohort Study.
- Source :
-
Journal of Women's Health (15409996) . Sep2024, Vol. 33 Issue 9, p1224-1232. 9p. - Publication Year :
- 2024
-
Abstract
- Background: Individuals with disabilities may require specific medications in pregnancy. The prevalence and patterns of medication use, overall and for medications with known teratogenic risks, are largely unknown. Methods: This population-based cohort study in Ontario, Canada, 2004–2021, comprised all recognized pregnancies among individuals eligible for public drug plan coverage. Included were those with a physical (n = 44,136), sensory (n = 13,633), intellectual or developmental (n = 2,446) disability, or multiple disabilities (n = 5,064), compared with those without a disability (n = 299,944). Prescription medication use in pregnancy, overall and by type, was described. Modified Poisson regression generated relative risks (aRR) for the use of medications with known teratogenic risks and use of ≥2 and ≥5 medications concurrently in pregnancy, comparing those with versus without a disability, adjusting for sociodemographic and clinical factors. Results: Medication use in pregnancy was more common in people with intellectual or developmental (82.1%), multiple (80.4%), physical (73.9%), and sensory (71.9%) disabilities, than in those with no known disability (67.4%). Compared with those without a disability (5.7%), teratogenic medication use in pregnancy was especially higher in people with multiple disabilities (14.2%; aRR 2.03, 95% confidence interval [CI]: 1.88–2.20). Furthermore, compared with people without a disability (3.2%), the use of ≥5 medications concurrently was more common in those with multiple disabilities (13.4%; aRR 2.21, 95% CI: 2.02–2.41) and an intellectual or developmental disability (9.3%; aRR 2.13, 95% CI: 1.86–2.45). Interpretation: Among people with disabilities, medication use in pregnancy is prevalent, especially for potentially teratogenic medications and polypharmacy, highlighting the need for preconception counseling/monitoring to reduce medication-related harm in pregnancy. [ABSTRACT FROM AUTHOR]
- Subjects :
- *POISSON distribution
*DRUG-induced abnormalities
*WOMEN
*RESEARCH funding
*DESCRIPTIVE statistics
*TERATOGENIC agents
*POLYPHARMACY
*LONGITUDINAL method
*INTELLECTUAL disabilities
*DEVELOPMENTAL disabilities
*PHYSICIAN practice patterns
*PRECONCEPTION care
*DRUGS
*DRUG prescribing
*COMPARATIVE studies
*CONFIDENCE intervals
*COUNSELING
*DRUG utilization
*PEOPLE with disabilities
*PREGNANCY
Subjects
Details
- Language :
- English
- ISSN :
- 15409996
- Volume :
- 33
- Issue :
- 9
- Database :
- Academic Search Index
- Journal :
- Journal of Women's Health (15409996)
- Publication Type :
- Academic Journal
- Accession number :
- 179466933
- Full Text :
- https://doi.org/10.1089/jwh.2023.1138